Gunnar Hilmar Gislason

Gunnar Hilmar Gislason serves as a Clinical Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. His specialization focuses on Internal Medicine with particular expertise in Cardiology. He maintains an active research profile with 899 total research outputs, demonstrating significant scholarly contributions to his field.

His primary research interests center around cardiovascular disease, particularly examining the intersection of cardiology with immunology through influenza vaccine studies, heart failure management, and register-based epidemiological research. His work frequently investigates clinical outcomes in elderly populations and examines the impact of various interventions on cardiovascular health. His research methodology often employs nationwide register-linked studies, providing robust population-level evidence for clinical practice.

Gislason's publication record shows a strong emphasis on high-impact clinical trials, particularly the DANFLU series examining influenza vaccine effectiveness in cardiovascular contexts. His work spans multiple sub-disciplines including vaccine effectiveness, heart failure pharmacotherapy, device implantation outcomes, and thromboembolic risk assessment. His research has garnered significant attention, with multiple publications picked up by news outlets and referenced across social media platforms.

His scholarly contributions have been disseminated through prestigious medical journals including the New England Journal of Medicine, European Heart Journal, and American Heart Journal, demonstrating the high impact of his research within the cardiology community.